Literature DB >> 20395209

The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.

Yinghui Song1, Jason A Aglipay, Joshua D Bernstein, Sumanta Goswami, Pamela Stanley.   

Abstract

The branching of complex N-glycans attached to growth factor receptors promotes tumor progression by prolonging growth factor signaling. The addition of the bisecting GlcNAc to complex N-glycans by Mgat3 has varying effects on cell adhesion, cell migration, and hepatoma formation. Here, we show that Chinese hamster ovary cells expressing Mgat3 and the polyoma middle T (PyMT) antigen have reduced cell proliferation and growth factor signaling dependent on a galectin lattice. The Mgat3 gene is not expressed in virgin mammary gland but is upregulated during lactation and is expressed in mouse mammary tumor virus (MMTV)/PyMT tumors. Mice lacking Mgat3 that cannot transfer the bisecting GlcNAc to N-glycans acquire PyMT-induced mammary tumors more rapidly and have an increased tumor burden, increased migration of tumor cells, and increased early metastasis to lung. Tumors and tumor-derived cells lacking Mgat3 exhibit enhanced signaling through the Ras pathway and reduced amounts of functionally glycosylated alpha-dystroglycan. Constitutive overexpression of an MMTV/Mgat3 transgene inhibits early mammary tumor development and tumor cell migration. Thus, the addition of the bisecting GlcNAc to complex N-glycans of mammary tumor cell glycoprotein receptors is a cell autonomous mechanism serving to retard tumor progression by reducing growth factor signaling. (c) 2010 AACR.

Entities:  

Keywords:  LEC10; MMTV/PyMT mammary tumors; Mgat3; bisecting GlcNAc; invasion; metastasis

Mesh:

Substances:

Year:  2010        PMID: 20395209      PMCID: PMC2856092          DOI: 10.1158/0008-5472.CAN-09-2719

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Polyoma virus middle T antigen and its role in identifying cancer-related molecules.

Authors:  Stephen M Dilworth
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

2.  Suppression of tumor growth and metastasis in Mgat5-deficient mice.

Authors:  M Granovsky; J Fata; J Pawling; W J Muller; R Khokha; J W Dennis
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

3.  Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII.

Authors:  Riddhi Bhattacharyya; Mantu Bhaumik; T Shantha Raju; Pamela Stanley
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

4.  Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors.

Authors:  Y Sato; M Takahashi; Y Shibukawa; S K Jain; R Hamaoka; Y Yaginuma; K Honke; M Ishikawa; N Taniguchi
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

5.  A glycomic approach to hepatic tumors in N-acetylglucosaminyltransferase III (GnT-III) transgenic mice induced by diethylnitrosamine (DEN): identification of haptoglobin as a target molecule of GnT-III.

Authors:  Atsuko Ekuni; Eiji Miyoshi; Jeong Heon Ko; Katsuhisa Noda; Takatoshi Kitada; Shinji Ihara; Takeshi Endo; Asako Hino; Koichi Honke; Naoyuki Taniguchi
Journal:  Free Radic Res       Date:  2002-08

6.  New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice.

Authors:  X Yang; M Bhaumik; R Bhattacharyya; S Gong; C E Rogler; P Stanley
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

7.  The collection of the motile population of cells from a living tumor.

Authors:  J B Wyckoff; J E Segall; J S Condeelis
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

8.  The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.

Authors:  Cristina Montagna; Myung-Soo Lyu; Kent Hunter; Luanne Lukes; William Lowther; Tricia Reppert; Bruce Hissong; Zoë Weaver; Thomas Ried
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

9.  Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.

Authors:  Takemitsu Nagahata; Akira Hirano; Yoshihito Utada; Shinichi Tsuchiya; Kaoru Takahashi; Takashi Tada; Masujirou Makita; Fujio Kasumi; Futoshi Akiyama; Goi Sakamoto; Yusuke Nakamura; Mitsuru Emi
Journal:  Breast Cancer       Date:  2002       Impact factor: 4.239

10.  Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity.

Authors:  Simon J North; Hung-Hsiang Huang; Subha Sundaram; Jihye Jang-Lee; A Tony Etienne; Alana Trollope; Sara Chalabi; Anne Dell; Pamela Stanley; Stuart M Haslam
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

View more
  41 in total

1.  Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

Authors:  Anas M Abdel Rahman; Michael Ryczko; Miyako Nakano; Judy Pawling; Tania Rodrigues; Anita Johswich; Naoyuki Taniguchi; James W Dennis
Journal:  Glycobiology       Date:  2014-10-01       Impact factor: 4.313

2.  Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy.

Authors:  Xiang Li; Dongliang Li; Xingchen Pang; Ganglong Yang; H Joachim Deeg; Feng Guan
Journal:  Exp Hematol       Date:  2015-05-01       Impact factor: 3.084

3.  Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition.

Authors:  Hsin-Yung Yen; Ying-Chih Liu; Nai-Yu Chen; Chia-Feng Tsai; Yi-Ting Wang; Yu-Ju Chen; Tsui-Ling Hsu; Pan-Chyr Yang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-13       Impact factor: 11.205

4.  Applying in-silico retention index and mass spectra matching for identification of unknown metabolites in accurate mass GC-TOF mass spectrometry.

Authors:  Sangeeta Kumari; Doug Stevens; Tobias Kind; Carsten Denkert; Oliver Fiehn
Journal:  Anal Chem       Date:  2011-06-28       Impact factor: 6.986

Review 5.  The bisecting GlcNAc in cell growth control and tumor progression.

Authors:  Hazuki E Miwa; Yinghui Song; Richard Alvarez; Richard D Cummings; Pamela Stanley
Journal:  Glycoconj J       Date:  2012-04-04       Impact factor: 2.916

6.  Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.

Authors:  Pamela Stanley; Subha Sundaram
Journal:  Curr Protoc Chem Biol       Date:  2014-06-03

7.  Bisecting GlcNAc Is a General Suppressor of Terminal Modification of N-glycan.

Authors:  Miyako Nakano; Sushil K Mishra; Yuko Tokoro; Keiko Sato; Kazuki Nakajima; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yasuhiko Kizuka
Journal:  Mol Cell Proteomics       Date:  2019-08-02       Impact factor: 5.911

Review 8.  Neural functions of bisecting GlcNAc.

Authors:  Yasuhiko Kizuka; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2018-06-16       Impact factor: 2.916

Review 9.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

10.  A testis-specific regulator of complex and hybrid N-glycan synthesis.

Authors:  Hung-Hsiang Huang; Pamela Stanley
Journal:  J Cell Biol       Date:  2010-08-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.